| Followers | 142 |
| Posts | 12918 |
| Boards Moderated | 0 |
| Alias Born | 01/21/2019 |
Wednesday, December 22, 2021 3:51:50 AM
The CEO here is also another con-artist in OTC. He should be investigated for fraud the moment he start releasing a news to pump the stock in order to dilute because the intention is to mislead the shareholders. Most OTC companies are pretty much run by criminals and serial scammers and RBGP CEO is no different. This is why 90% of all OTC stocks in 2021 hit 52-wk low price because of undelivered promises. Criminals and serial scammers are crowding the OTC companies and they are feasting shareholders investments. The SEC has allowed these low-life, criminals and scammers to exist and thrive at investor's expense.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM

